TLSI Q1 2022 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2M

Gross Profit

$2M84.1% margin

Operating Income

-$8M-333.0% margin

Net Income

-$8M-332.2% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-7.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$62,000

Balance Sheet

Total Assets

$250M

Total Liabilities

$14M

Stockholders' Equity

$236M

Cash & Equivalents

$50,930

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	$0	—
Operating Income	-$8M	-$307,992	-2462.1%
Net Income	-$8M	-$372,034	-2016.2%